GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
51
c/t2dglp1·posted 1 months ago by u/hugo_norgaard

[Results] 37 weeks on 15mg, full numbers, ask me anything boring

Results

37 weeks on 15mg, full numbers, ask me anything boring. This is a description of what happened to me and not a plan for anybody else.

To save the first four comments: 37 weeks and 15mg.

Panicked over a first-day sensor reading and rebuilt my week around it. It was the sensor.

Time in range told me far more than the average did. Two quarters with the same A1c looked completely different on the sensor.

Screenshot none of this. Read the whole thread, including the parts where I am told I am wrong.

64 up / 13 down84% upvoted15 commentsid 1tos0f26 Jun 2026

15 comments

15 in this archive, depth 4

best — the order this archive was captured in

u/teodor_duarte-7 points·1 months ago

Continuous monitoring shows the shape: postprandial excursions, overnight behaviour and time in range. Two people with identical A1c can have very different distributions.

replysharereportpermalink
u/rasmus_kimani13 points·1 months ago

postprandial excursions are where most of the improvement shows up first

replysharereportpermalink
u/sock_puppet_spotter5 points·1 months ago

Right, and the diabetes programmes report glycaemic endpoints. Quoting an obesity trial result here is answering a different question.

replysharereportpermalink
u/amylin_amyamylin6 points·1 months ago

Agreed on variability. Two people with the same average can have completely different days.

replysharereportpermalink
u/gradient_goblin4 points·1 months ago·edited

Is that a first-day sensor reading?

replysharereportpermalink
u/hamza_weiss3 points·1 months ago

Disagree — that is an obesity trial endpoint and this thread is about glycaemic control.

replysharereportpermalink
u/hugo_norgaardOP5 points·1 months ago

Have you taken this to whoever manages your diabetes?

replysharereportpermalink
[removed]4 points·1 months ago

[removed by moderator]

replysharereportpermalink
u/reship_roulette6 points·1 months ago

Same. The first day of a new sensor is unreliable and people rebuild their whole week around it.

replysharereportpermalink
u/neha_rahimi6 points·1 months ago

Sensor accuracy varies across wear, and readings on the first day are the least reliable. Calibration practice and compression artefacts explain many alarming single values.

replysharereportpermalink
u/sigrid_kaufmann5 points·1 months ago

the fasting number is the one people fixate on and it moves last

replysharereportpermalink
u/nora_ramos3 points·1 months ago

Not convinced. Hypoglycaemia risk from this class alone is low; the risk you are describing comes from the combination.

replysharereportpermalink
u/neha_falk3 points·1 months ago

Are you quoting a diabetes trial or an obesity one?

replysharereportpermalink
u/tomas_lokken4 points·1 months ago

Kept fingersticks alongside the sensor for two weeks to sanity-check it. Worth doing once.

replysharereportpermalink
u/neha_falk0 points·1 months ago

This. Hypoglycaemia risk in this class is driven mostly by the other agents in the regimen.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.